Latest NxStage Medical Inc. Stories
LAWRENCE, Mass., Oct. 5, 2011 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM) is a leading manufacturer of innovative dialysis products and together with its patients and their care partners is leading the home hemodialysis revolution. Because of their passion and enthusiasm, NxStageUsers, together with thousands of other patients, continue to fuel the growth of NxStage by helping to change the dialysis treatment paradigm and give dialysis patients greater access to quality care,...
LAWRENCE, Mass., Oct. 3, 2011 /PRNewswire/ -- NxStage(®) Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today applauded the efforts of its home hemodialysis patients together with the National Kidney Foundation (NKF) and Dialysis Patient Citizens (DPC), in advocating for improvements in the quality of care for end stage renal disease (ESRD) patients with lawmakers. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) NxStage home...
LAWRENCE, Mass., Sept. 26, 2011/PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Barry M. Straube, M.D., a member of its Board of Directors, was honored with the Peter Lundin, MD Award from the American Association of Kidney Patients (AAKP) at the organization's 38th Annual Convention in August. The AAKP presents the award yearly to an outstanding renal physician who makes contributions to the care, welfare and...
LAWRENCE, Mass., Sept. 23, 2011 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today commented on the just-released findings of an NIH sponsored study which shows that event rates, including mortality, were significantly higher for patients following the long (2-day) interdialytic interval associated with a three times per week dialysis schedule ("conventional dialysis"). The study entitled "Long Interdialytic Interval and...
LAWRENCE, Mass., Sept. 8, 2011 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer, will present at the UBS Global Life Sciences Conference on Tuesday, September 20th, at 3:00 p.m. ET. A webcast of the event will be made available at http://www.nxstage.com/ir.cfm at the time of the presentation. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) About...
LAWRENCE, Mass., Sept. 1, 2011 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that its Chief Executive Officer, Jeffrey H. Burbank, is among the recipients of Mass High Tech, The Voice of New England Innovation, 2011 All-Stars Awards. The All-Stars Awards recognize 15 driven and influential leaders of New England's innovation economy. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) The 2011...
LAWRENCE, Mass., Aug. 29, 2011 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that former NxStage® System One(TM) patient Tederra Coleman is celebrating the one-year anniversary of her successful kidney transplant. Coleman, 33, of Pompano Beach, Florida, received her transplant after experiencing two years of daily home hemodialysis with the NxStage System One(TM). Prior to beginning daily home...
LAWRENCE, Mass., Aug. 26, 2011 /PRNewswire/ -- As potential hurricanes and severe weather approach, NxStage(®) Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, is reminding patients that it is important to be prepared to ensure continuity of therapy in the event of a natural disaster or other potentially disruptive non-medical event. NxStage's "Are You Ready" is a comprehensive emergency preparedness guidebook to help patients using NxStage Medical's...
LAWRENCE, Mass., Aug. 15, 2011 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, is celebrating Indiana University Health's (IU Health) seventh anniversary of its program to offer home hemodialysis to patients with the NxStage System One(TM). IU Health started its home dialysis program by partnering with NxStage on its Investigational Device Exemption (IDE) study for U.S. Food and Drug Administration (FDA) clearance to market...
LAWRENCE, Mass., Aug 5, 2011 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer and Robert Brown, Chief Financial Officer, will participate in the following schedule of investor conferences. A webcast of the event will be made available at http://www.nxstage.com/ir.cfm at the time of each conference. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO )...
